Search

everythinglearnresearchcommunity

for

Search:↓

A woman's total hair loss from hepatitis C treatment grew back after stopping the medication.

Current and future treatments for alopecia areata focus on immunosuppression, immunomodulation, and protecting hair follicles.

Teriflunomide is an effective and generally safe oral treatment for relapsing MS, reducing relapses and slowing disability progression.

Androgens may influence T cells, contributing to higher autoimmune liver disease risk in women.

Topical tofacitinib may grow hair better than minoxidil by increasing VEGF and reducing inflammation.

Some patients may experience temporary total hair loss from hepatitis C treatment with PEG-interferon and ribavirin.

Dupilumab for atopic dermatitis may cause new or worsen existing alopecia areata.

Acitretin is effective for severe psoriasis and can be used long-term due to no immunosuppression, but must be carefully monitored for side effects and is not for pregnant women.

Some skin conditions are common during pregnancy and can be safely treated without affecting the pregnancy outcome.

Alopecia areata, a type of hair loss, is likely an autoimmune disease with a genetic link, but its exact cause is still unknown.

Zinc supplementation may help improve treatment outcomes for chronic hepatitis C.

Some cases of tinea capitis, a fungal scalp infection, can look like scarring hair loss due to the body's immune response and the fungus itself.

Rumex japonicus Houtt. may be an effective treatment for atopic dermatitis by reducing inflammation.

New psoriasis treatments are effective but come with side effects and risks.

PGD2 increases androgen receptor activity in hair cells, which could be targeted to treat hair loss.

Tofacitinib nanoparticles can safely and effectively treat alopecia areata by targeting hair follicles.

New JAK inhibitor drugs show promise for treating skin diseases but need more research on safety and effectiveness.

Optimizing the structure of a specific compound greatly improved its effectiveness and precision for treating diabetic complications.

Dupilumab for skin problems might reactivate hair loss in some patients.

Women with Systemic Lupus Erythematosus should have closely monitored pregnancies and avoid certain medications to improve their pregnancy outcomes.

Targeting immune tolerance issues in Alopecia Areata could restore hair growth and maintain remission.

Men are more likely to have severe respiratory viral infections like COVID-19 due to hormonal and genetic differences, while women generally have stronger immune responses.

The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.

Calcipotriol works almost as well as clobetasol for mild to moderate alopecia areata with fewer side effects.

Treating alopecia areata every 3 weeks with diphenylcyclopropenone is more effective than weekly treatments.

New genes linked to ichthyosis were found, but there's still no cure; treatment options are improving.

Certain drugs are effective for skin conditions like psoriasis, vitiligo, and hair loss.

Graphene oxide helps deliver a skin healing agent over time, improving skin and hair follicle regeneration.

Blocking interferon-gamma might help treat various autoimmune diseases.

Increased PPARGC1α relates to hair thinning in common baldness.